Adaptive Nutraceutical Gel Systems
Legal Citation
Summary of the Inventive Concept
Next-generation nutraceutical gel systems that adapt to individual users' needs, leveraging self-healing matrices, personalized compositions, and bio-responsive properties to revolutionize the nutraceutical industry.
Background and Problem Solved
The original nutraceutical gel patent, while innovative, has limitations in terms of customization, adaptability, and user-centric design. The new inventive concept addresses these limitations by envisioning a paradigm shift in nutraceutical gel technology, incorporating cutting-edge materials and AI-driven design principles.
Detailed Description of the Inventive Concept
The new inventive concept comprises four key components: self-healing matrices, personalized compositions, wearable devices, and AI-powered digital platforms. The self-healing matrix enables the gel to reform its structure in response to environmental stimuli, ensuring optimal delivery of immune modulators. Personalized compositions are generated through AI-driven analysis of users' genetic profiles and health data, allowing for customized nutritional support. Wearable devices integrate sensor systems to monitor users' health metrics and release immune modulators as needed. The digital platform enables users to design and manufacture customized nutraceutical gels, leveraging a database of nutritional profiles and health data.
Novelty and Inventive Step
The new claims introduce the concept of self-healing matrices, personalized compositions, wearable devices, and AI-powered digital platforms, which are not present in the original patent. These innovations provide a significant departure from the state of the art, enabling a new generation of adaptive nutraceutical gel systems.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different materials for the self-healing matrix, such as graphene or nanocellulose. Variations of the wearable device could include implantable or injectable forms, while the digital platform could be expanded to incorporate additional health data sources, such as wearable fitness trackers or electronic health records.
Potential Commercial Applications and Market
The adaptive nutraceutical gel systems have vast commercial potential in the nutraceutical, pharmaceutical, and healthcare industries. Target markets include personalized nutrition, preventative healthcare, and precision medicine. The digital platform and wearable devices could also be licensed to major healthcare companies, generating significant revenue streams.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K36/889 |
| A | A23 | A23G4/12 |
| A | A23 | A23L29/231 |
| A | A23 | A23L29/238 |
| A | A23 | A23L29/27 |
| A | A23 | A23L29/271 |
| A | A23 | A23L29/284 |
| A | A23 | A23L33/10 |
| A | A23 | A23L33/105 |
| A | A61 | A61K36/185 |
| A | A61 | A61K36/35 |
| A | A61 | A61K36/87 |
| A | A61 | A61K47/36 |
| A | A23 | A23V2002/00 |
| A | A23 | A23V2200/324 |
| A | A23 | A23V2250/21 |
| A | A23 | A23V2250/21166 |
| A | A23 | A23V2250/506 |
| A | A23 | A23V2250/5086 |
| A | A23 | A23V2250/708 |
| A | A61 | A61K2300/00 |
Original Patent Information
| Patent Number | US 11,857,593 |
|---|---|
| Title | Nutraceutical gels |
| Assignee(s) | 4Life Patents, LLC |